Cargando…

Respiratory muscle dysfunction in long-COVID patients

PURPOSE: Symptoms often persistent for more than 4 weeks after COVID-19—now commonly referred to as ‘Long COVID’. Independent of initial disease severity or pathological pulmonary functions tests, fatigue, exertional intolerance and dyspnea are among the most common COVID-19 sequelae. We hypothesize...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hennigs, Jan K., Huwe, Marie, Hennigs, Annette, Oqueka, Tim, Simon, Marcel, Harbaum, Lars, Körbelin, Jakob, Schmiedel, Stefan, Schulze zur Wiesch, Julian, Addo, Marylyn M., Kluge, Stefan, Klose, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108020/ https://www.ncbi.nlm.nih.gov/pubmed/35570238 http://dx.doi.org/10.1007/s15010-022-01840-9

Ejemplares similares

Organbezogene Folgeerscheinungen von COVID‑19 bei Erwachsenen
por: Hennigs, Jan K., et al.
Publicado: (2022)

Genetic evidence for a causative effect of airflow obstruction on left ventricular filling: a Mendelian randomisation study
por: Harbaum, Lars, et al.
Publicado: (2021)

Endoscopic lung volume reduction coil treatment in patients with chronic hypercapnic respiratory failure: an observational study
por: Simon, Marcel, et al.
Publicado: (2016)

Comparison of clinical characteristics and disease outcome of COVID-19 and seasonal influenza
por: Brehm, Thomas Theo, et al.
Publicado: (2021)

Transcription factors in the pathogenesis of pulmonary arterial hypertension—Current knowledge and therapeutic potential
por: Körbelin, Jakob, et al.
Publicado: (2023)

Endoscopic lung volume reduction coil treatment in patients with very low FEV(1): an observational study
por: Simon, Marcel, et al.
Publicado: (2018)

The Endothelial ADMA/NO Pathway in Hypoxia-Related Chronic Respiratory Diseases
por: Lüneburg, Nicole, et al.
Publicado: (2014)

Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19
por: Woo, Marcel S., et al.
Publicado: (2021)

Malaria in the Time of COVID-19: Do Not Miss the Real Cause of Illness
por: Jochum, Johannes, et al.
Publicado: (2021)

Residual risk identified in routine noninvasive follow-up assessments in pulmonary arterial hypertension
por: Ostermann, Jonna, et al.
Publicado: (2023)

Management der saisonalen Influenza 2017/2018: Erfahrungen an einem deutschen Universitätsklinikum
por: Kraef, Christian, et al.
Publicado: (2019)

Vascular Endothelial Cells: Heterogeneity and Targeting Approaches
por: Hennigs, Jan K., et al.
Publicado: (2021)

Acute effects of exercise on the inflammatory state in patients with idiopathic pulmonary arterial hypertension
por: Harbaum, Lars, et al.
Publicado: (2016)

Fiber optic bronchoscopy in patients with acute hypoxemic respiratory failure requiring noninvasive ventilation - a feasibility study
por: Baumann, Hans Jörg, et al.
Publicado: (2011)

Safety and efficacy of protease inhibitor based combination therapy in a single-center “real-life” cohort of 110 patients with chronic hepatitis C genotype 1 infection
por: Wehmeyer, Malte H, et al.
Publicado: (2014)

Tecovirimat for the treatment of severe Mpox in Germany
por: Hermanussen, Lennart, et al.
Publicado: (2023)

Frequency of IRF5+ dendritic cells is associated with the TLR7-induced inflammatory cytokine response in SARS-CoV-2 infection
por: Cords, Leon, et al.
Publicado: (2023)

Sotrovimab in Hospitalized Patients with SARS-CoV-2 Omicron Variant Infection: a Propensity Score-Matched Retrospective Cohort Study
por: Woo, Marcel S., et al.
Publicado: (2022)

Frequent neurocognitive deficits after recovery from mild COVID-19
por: Woo, Marcel S, et al.
Publicado: (2020)

Clinical phenotyping of plasma thrombospondin-2 reveals relationship to right ventricular structure and function in pulmonary hypertension
por: Dittrich, Anna M., et al.
Publicado: (2023)

N-Terminal Pro-Brain Natriuretic Peptide Is a Useful Prognostic Marker in Patients with Pre-Capillary Pulmonary Hypertension and Renal Insufficiency
por: Harbaum, Lars, et al.
Publicado: (2014)

Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for severe acute respiratory syndrome coronavirus 2 delta and omicron variants
por: Brehm, Thomas Theo, et al.
Publicado: (2022)

Granulomatosis with polyangiitis: mind the airway
por: Oqueka, Tim, et al.
Publicado: (2020)

Remdesivir-induced emergence of SARS-CoV2 variants in patients with prolonged infection
por: Heyer, Andreas, et al.
Publicado: (2022)

Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension?
por: Hennigs, Jan K, et al.
Publicado: (2011)

Low intensity, long-term outpatient rehabilitation in COPD: a randomised controlled trial
por: Baumann, Hans Jörg, et al.
Publicado: (2012)

High burden of RSV and influenza in patients presenting with suspected pneumonia in the emergency room of a German tertiary hospital in fall of 2022
por: Ettemeyer, Marlene, et al.
Publicado: (2023)

Non-Invasive Risk Prediction Based on Right Ventricular Function in Patients with Pulmonary Arterial Hypertension
por: Qaderi, Vazhma, et al.
Publicado: (2021)

Fibrinogen plasma concentration is an independent marker of haemodynamic impairment in chronic thromboembolic pulmonary hypertension
por: Hennigs, Jan K., et al.
Publicado: (2014)

Exploratory analysis of the neutrophil to lymphocyte ratio in patients with pulmonary arterial hypertension
por: Harbaum, Lars, et al.
Publicado: (2017)

Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study
por: Brehm, Thomas Theo, et al.
Publicado: (2021)

Evidence of surface contamination in hospital rooms occupied by patients infected with monkeypox, Germany, June 2022
por: Nörz, Dominik, et al.
Publicado: (2022)

Patient Characteristics and Clinical Course of COVID-19 Patients Treated at a German Tertiary Center during the First and Second Waves in the Year 2020
por: Brehm, Thomas Theo, et al.
Publicado: (2021)

Liver Cirrhosis as a Risk Factor for Direct-Acting Antiviral Therapy Failure in Real-Life Hepatitis C Virus/Human Immunodeficiency Virus Coinfection
por: Boesecke, Christoph, et al.
Publicado: (2017)

Safety and efficacy of elvitegravir, dolutegravir, and raltegravir in a real-world cohort of treatment-naïve and -experienced patients
por: Brehm, Thomas Theo, et al.
Publicado: (2019)

High‐resolution analysis of individual spike peptide‐specific CD4 (+) T‐cell responses in vaccine recipients and COVID‐19 patients
por: Karsten, Hendrik, et al.
Publicado: (2022)

Erratum zu: Milde COVID-19-Verläufe bei Mitarbeitenden einer Universitätsklinik: Die „erste Welle“ am Universitätsklinikum Hamburg-Eppendorf
por: von Felden, Johann, et al.
Publicado: (2021)

Milde COVID-19-Verläufe bei Mitarbeitenden einer Universitätsklinik: Die „erste Welle“ am Universitätsklinikum Hamburg-Eppendorf
por: von Felden, Johann, et al.
Publicado: (2021)

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients
por: Beisel, Claudia, et al.
Publicado: (2014)

Risk factors for worsening of somatic symptom burden in a prospective cohort during the COVID-19 pandemic
por: Engelmann, Petra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ndk5h0i0v1fqrsebpr8utcmlng